5-MeO-MET
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H20N2O |
| Molar mass | 232.327 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-MeO-MET, also known as 5-methoxy-N-methyl-N-ethyltryptamine, is a relatively rare designer drug from the tryptamine family, related to compounds such as methylethyltryptamine (MET) and 5-MeO-DMT. It was first synthesised in the 1960s and was studied to a limited extent, with studies finding it to be more potent in animal behavioral tests than 5-MeO-DMT. It was first identified on the illicit market in June 2012 in Sweden. It was made illegal in Norway in 2013, and is controlled under analogue provisions in numerous other jurisdictions.